Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KORNEK, Gabriela")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 24 of 24

  • Page / 1
Export

Selection :

  • and

Targeted Therapies in Solid Tumours: Pinpointing the Tumour's Achilles HeelKORNEK, Gabriela; SELZER, Edgar.Current pharmaceutical design (Print). 2009, Vol 15, Num 2, pp 207-242, issn 1381-6128, 36 p.Article

Update on ocular complications of systemic cancer chemotherapySCHMID, Katharina E; KORNEK, Gabriela V; SCHEITHAUER, Werner et al.Survey of ophthalmology. 2006, Vol 51, Num 1, pp 19-40, issn 0039-6257, 22 p.Article

Limited Value of CA 19-9 in Predicting Early Treatment Failure in Patients with Advanced Pancreatic CancerVORMITTAG, Laurenz; GLEISS, Andreas; SCHEITHAUER, Werner et al.Oncology. 2009, Vol 77, Num 2, pp 140-146, issn 0030-2414, 7 p.Article

Expression levels of Akt in nimesulide-treated squamous carcinoma cell lines of the head and neckVORMITTAG, Laurenz; LAMM, Wolfgang; EROVIC, Boban M et al.Oncology reports. 2005, Vol 13, Num 2, pp 207-210, issn 1021-335X, 4 p.Article

Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabineULRICH-PUR, Herbert; KORNEK, Gabriela Verena; FIEBIGER, Wolfgang et al.Oncology. 2001, Vol 60, Num 4, pp 313-315, issn 0030-2414Article

Activity of chemotherapy in the palliative treatment of salivary gland tumors : review of the literatureRIZK, Sophia; ROBERT, Annie; VANDENHOOFT, Annick et al.European archives of oto-rhino-laryngology. 2007, Vol 264, Num 6, pp 587-594, issn 0937-4477, 8 p.Article

Treatment and outcome of intrahepatic cholangiocellular carcinomaPUHALLA, Harald; SCHUELL, Birgit; POKORNY, Herwig et al.The American journal of surgery. 2005, Vol 189, Num 2, pp 173-177, issn 0002-9610, 5 p.Article

Mcl-1,vascular endothelial growth factor-R2, and 14-3-3σ expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neckEROVIC, Boban M; PEIZMANN, Martina; GRASL, Matthäus Ch et al.Clinical cancer research. 2005, Vol 11, Num 24, pp 8632-8636, issn 1078-0432, 5 p., 1Article

Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neckKEIL, Felix; SELZER, Edgar; BURIAN, Martin et al.European journal of cancer (1990). 2013, Vol 49, Num 2, pp 352-359, issn 0959-8049, 8 p.Article

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients : results from the Vienna Cancer and Thrombosis Study (CATS). CommentaryRICKLES, Frederick R; AY, Cihan; ZIELINSKI, Christoph et al.Blood. 2008, Vol 112, Num 7, issn 0006-4971, 2594-2595, 2703-2708 [8 p.]Article

Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factorKWASNY, Werner; KORNEK, Gabriela; HAIDER, Karin et al.Breast cancer research and treatment. 2000, Vol 63, Num 3, pp 235-241, issn 0167-6806Article

Effective combination chemotherapy with bimonthly docetaxel and cisplatin with or without hematopoietic growth factor support in patients with advanced gastroesophageal cancerSCHÜLL, Birgit; KORNEK, Gabriela V; SCHMID, Katharina et al.Oncology. 2003, Vol 65, Num 3, pp 211-217, issn 0030-2414, 7 p.Article

Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabineKORNEK, Gabriela V; PÖTTER, Richard; SELZER, Edgar et al.International journal of radiation oncology, biology, physics. 2001, Vol 49, Num 3, pp 665-671, issn 0360-3016Article

Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: Results of a Phase I-II TrialSCHEITHAUER, Werner; KORNEK, Gabriela V; ULRICH-PUR, Herbert et al.Cancer. 2001, Vol 91, Num 7, pp 1264-1271, issn 0008-543XArticle

Oxaliplatin-induced fever and release of IL-6ULRICH-PUR, Herbert; FIEBIGER, W. C. C; SCHÜLL, B et al.Oncology. 2000, Vol 59, Num 3, pp 187-189, issn 0030-2414Article

Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltrationMEYER, Brigitte; KORNEK, Gabriela V; NIKFARDJAM, Mariam et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 1, pp 172-179, issn 0305-7453, 8 p.Article

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynxGLASER, Christoph M; MILLESI, Werner; KORNEK, Gabriela V et al.International journal of radiation oncology, biology, physics. 2001, Vol 50, Num 3, pp 705-715, issn 0360-3016Article

Randomized multicenter phase II trial of oxaliplatin plus Irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancerSCHEITHAUER, Werner; KORNEK, Gabriela V; LENAUER, Alfred et al.Journal of clinical oncology. 2002, Vol 20, Num 1, pp 165-172, issn 0732-183XArticle

Randomized phase II study of Irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerSCHEITHAUER, Werner; KORNEK, Gabriela V; BRUGGER, Stefan et al.Cancer investigation. 2002, Vol 20, Num 1, pp 60-68, issn 0735-7907Article

Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factorKORNEK, Gabriela V; ULRICH-PUR, Herbert; PENZ, Melitta et al.Journal of clinical oncology. 2001, Vol 19, Num 3, pp 621-627, issn 0732-183XArticle

Randomized multicenter phase II trial of two different schedules of Capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancerSCHEITHAUER, Werner; KORNEK, Gabriela V; RADERER, Markus et al.Journal of clinical oncology. 2003, Vol 21, Num 7, pp 1307-1312, issn 0732-183X, 6 p.Article

Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factorKORNEK, Gabriela V; HAIDER, Karin; KWASNY, Werner et al.Clinical cancer research. 2002, Vol 8, Num 5, pp 1051-1056, issn 1078-0432Article

Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone : A Randomized Multicenter Phase III Clinical Trial-SAKK 44/00-CECOG/ PAN.1.3.001BERNHARD, Jürg; DIETRICH, Daniel; BAUER, Jean et al.Journal of clinical oncology. 2008, Vol 26, Num 22, pp 3695-3701, issn 0732-183X, 7 p.Article

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: A randomized, multicenter, phase III trial of the swiss group for clinical cancer research and the central European Cooperative Oncology GroupHERRMANN, Richard; BODOKY, György; KDHNE, Claus-Henning et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2212-2217, issn 0732-183X, 6 p.Article

  • Page / 1